METASTATIC GASTRIC CANCER
Clinical trials for METASTATIC GASTRIC CANCER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC GASTRIC CANCER trials appear
Sign up with your email to follow new studies for METASTATIC GASTRIC CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Tailored immunotherapy cocktail shows promise for tough stomach cancer
Disease control CompletedThis phase 2 trial tested personalized immunotherapy combinations for advanced gastric cancer that had worsened after initial chemotherapy. Researchers matched treatments to tumor genetics: patients with certain genetic features received atezolizumab plus ipatasertib, while other…
Matched conditions: METASTATIC GASTRIC CANCER
Phase: PHASE2 • Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New radioactive tracer could spot hidden HER2 cancers
Diagnosis CompletedThis pilot study tested a new radioactive tracer called 89Zr-DFO*-trastuzumab in 6 people with HER2-positive breast or gastric cancer. The tracer is designed to attach to HER2 proteins on cancer cells and show up on PET scans. Participants received one injection and had up to 4 P…
Matched conditions: METASTATIC GASTRIC CANCER
Phase: NA • Sponsor: Amsterdam UMC, location VUmc • Aim: Diagnosis
Last updated Jun 27, 2026 12:37 UTC
-
Spirulina supplement tested to stop chemo nerve pain
Symptom relief CompletedThis study tested whether Phycocare, a supplement made from spirulina, can reduce nerve damage caused by the chemotherapy drug oxaliplatin in people with metastatic gastrointestinal cancers. 73 participants took either Phycocare or a placebo daily for 9 months. The goal was to se…
Matched conditions: METASTATIC GASTRIC CANCER
Phase: NA • Sponsor: Nantes University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC